Condition
Hand Dermatitis
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03703895Phase 4CompletedPrimary
A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis
NCT04375410Completed
Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic
NCT01950494Not ApplicableCompletedPrimary
FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults
Showing all 3 trials